Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics ...

(MENAFN- EIN Presswire) EINPresswire/ -- "The chromosomal microarray reflex testing market is witnessing significant growth as advancements in genetic diagnostics continue to transform healthcare.

A DNA index cutoff ≥1.10 delivered excellent discrimination for HHD (AUC 0.947) with high sensitivity and near-rule-out performance when negative (NPV 99.1%). Karyotype failure occurred in 25.2%, and ...

1.0 Market Revenue Segmentation Breakdown for Chromosomal Microarray Analysis (cma) Testing Market The Chromosomal Microarray Analysis (cma) Testing Market exhibits a complex revenue landscape driven ...

The Japan Chromosomal Microarray Analysis (CMA) Testing Market is divided by product type, application area, end-use industry and region. 📥 Download Sample 💰 Get Special Discount Japan Chromosomal ...

Clinicians should prioritize genetic testing for young children who show signs of intellectual disability (ID) or developmental delays, according to a new report from the American Academy of ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Prenatal diagnoses of congenital malformations have increased significantly in recent years with use of high-resolution prenatal imaging. Despite more precise radiological diagnoses, discussions with ...

Try these tests to evaluate your strength and cardiovascular fitness. Credit... Supported by By Hilary Achauer Photographs by Ashley Barker How do you know if you are fit? Or, at least, fit enough?

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...